Danilov, A. V., Flinn, I. W., Davids, M. S., Gregory, B., Bentur, O., Sidransky, D. and Brown, J. R. (2020) “The phase III DUO trial of PI3K inhibitor duvelisib <i>versus</i&gt; ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final analysis including overall survival”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.285043.